<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mauri G</submitter><funding>Fondazione Oncologia Niguarda Onlus</funding><funding>Fondazione Regionale Ricerca Biomedica Regione Lombardia</funding><pagination>e885-e889</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10850832</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(e3)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Early-onset colorectal cancer (EO-CRC) incidence is increasing, raising a clinical challenge. Clinicians tend to treat EO-CRC patients with more intensive regimens despite the lack of survival benefits, based on an age-related bias. Limited evidence is available regarding treatment-related toxicities in this peculiar subset of patients.&lt;h4>Methods&lt;/h4>We performed a literature search in MEDLINE/PubMed, EMBASE and Scopus, looking for reporting of nausea, vomiting and diarrhoea occurring in patients with EO-CRC, defined by age lower than 50 years old at initial diagnosis, while receiving anticancer treatment.&lt;h4>Results&lt;/h4>2318 records were screened and 9 full-text articles were considered eligible for inclusion for a total of 59 783 patients (of whom 8681 EO-CRC patients</pubmed_abstract><journal>BMJ supportive &amp; palliative care</journal><pubmed_title>Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.</pubmed_title><pmcid>PMC10850832</pmcid><funding_grant_id>CP 12/2018</funding_grant_id><pubmed_authors>Siena S</pubmed_authors><pubmed_authors>Artale S</pubmed_authors><pubmed_authors>Sartore-Bianchi A</pubmed_authors><pubmed_authors>Bonazzina E</pubmed_authors><pubmed_authors>Pedrazzoli P</pubmed_authors><pubmed_authors>Mariano S</pubmed_authors><pubmed_authors>Serra F</pubmed_authors><pubmed_authors>Mauri G</pubmed_authors><pubmed_authors>Cavestro GM</pubmed_authors><pubmed_authors>Pedrani M</pubmed_authors><pubmed_authors>Ghezzi S</pubmed_authors><pubmed_authors>Bencardino K</pubmed_authors><pubmed_authors>Caccialanza R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.</name><description>&lt;h4>Objectives&lt;/h4>Early-onset colorectal cancer (EO-CRC) incidence is increasing, raising a clinical challenge. Clinicians tend to treat EO-CRC patients with more intensive regimens despite the lack of survival benefits, based on an age-related bias. Limited evidence is available regarding treatment-related toxicities in this peculiar subset of patients.&lt;h4>Methods&lt;/h4>We performed a literature search in MEDLINE/PubMed, EMBASE and Scopus, looking for reporting of nausea, vomiting and diarrhoea occurring in patients with EO-CRC, defined by age lower than 50 years old at initial diagnosis, while receiving anticancer treatment.&lt;h4>Results&lt;/h4>2318 records were screened and 9 full-text articles were considered eligible for inclusion for a total of 59 783 patients (of whom 8681 EO-CRC patients</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2026-06-12T05:52:52.261Z</modification><creation>2026-06-12T03:08:26.868Z</creation></dates><accession>S-EPMC10850832</accession><cross_references><pubmed>37344158</pubmed><doi>10.1136/spcare-2023-004203</doi></cross_references></HashMap>